Macroeconomic Monitor
Home / Economy / Healthcare (page 5)

Healthcare

TEAM in the media about the new pension formula and healthcare problems

The topics of the participation of authors from the EKIP in March concerned: social security, healthcare, religion. Editor-in-chief Georgi Vuldjev, in the news of bTV, shared his concern about the falsification of documents for receiving a pension. According to him, there is no archival information available about what insurance contributions individuals have paid and to what extent …

More »

TEAM in the media on drug policy, the pension system and the euro

We started 2019 with a strong start – the topic of healthcare is hot again and the EKIP presented a new study: Proposal for a rational drug policy. The author of the analysis, health economist Arkadi Sharkov, was a guest on one of the most watched shows on the domestic airwaves – “Face to Face” on BTV. According to him, for …

More »

Proposal for a rational drug policy

This article is a summary of our new analysis and proposal for reform of the drug policy in Bulgaria. What did we find out? The analysis covers 56% of health-insured persons and 40% of the funds reimbursed by the NHIF and includes 4 groups of diseases: cardiovascular, malignant tumors, diabetes mellitus and rheumatoid. In 2016, over 2.5 million health-insured …

More »

TEAM in the media about the economy, incomes and necessary reforms in 2019

Despite the festive mood in December, EKIP experts again actively participated in the public debate on topics such as healthcare, the 2019 budget, and freedom of speech. The month began with the participation of EKIP Editor-in-Chief Georgi Vuldjev in the show “Q&A with Klara Marinova”, where he commented on the economic factors behind the November protests, political stability, …

More »

TEAM in the media for urban planning, healthcare and international politics

In the penultimate month of the year, the Bulgarian media again actively sought the expertise of the authors of the EKIP. Particular attention was paid to the topic of “urban planning” on the occasion of the report “Urban Planning Policy in Sofia” published at the beginning of the month with recommendations for improving urban planning policy. The problems with parking were commented on by our chairman Stoyan …

More »

Health Budget 2019 – More Money, Low Efficiency, and Possible Reforms?

health budget 2019

Main picture This year, healthcare spending increased by another 490 million leva, with the NHIF budget reaching 4.35 billion leva. As every year, the budget increases, with the percentage change compared to the previous year 2018 being 11%. This year, there is no change in the insurance burden, with health insurance remaining at 8%. This should not reassure …

More »

Some doubts about the new health insurance models

When we talk about health, does more money equal better quality? How accessible is medical care in Bulgaria? What are the useful moves before the institutions? The state of the system Questions like the above have been asked annually, and this year marks twenty years since the beginning of the reform. A beginning that is not …

More »

EKIP in the media about healthcare reform and price control ideas

The month was marked by the extremely high activity of our health economist Arkadi Sharkov in the media. Currently, a deep public debate is underway in our country regarding the problems in the healthcare system and the necessary reforms that can solve them. Sharkov and others took an active part in this debate in all possible ways …

More »

TEAM in the media about healthcare, pensions and the economy of Bulgaria

Over the past month, the TEAM has actively participated in public debates on a number of topics, the most key of which were healthcare, the economy of Bulgaria and Europe, and the international situation. Healthcare Our Deputy Chairman and health expert Arkadi Sharkov has been extremely active in the public space over the past month and has touched on the various problems of healthcare in Bulgaria. …

More »

The valsartan drama turned out to be a storm in a teacup

A few weeks ago, the scandal with the "carcinogenic valsartan" erupted, which quickly swept the media and created the prerequisites for numerous speculations about the quality of medications from this group. We at EKIP reacted quickly by publishing an article by M.A. Pharm. Dimitar Galabov, who clearly explained the problem, emphasizing that there is no need to panic. What a …

More »